a year ago
BHVN
Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
---|---|---|---|---|---|
Scholar Rock Holding CorpSRRK | +397.74% | $7.07 | $35.19 | 2024-10-03 - 2025-10-02 | Strong Buy |
Dyne Therapeutics IncDYN | +307.09% | $10.58 | $43.07 | 2023-08-09 - 2024-08-08 | Strong Buy |
Lexeo Therapeutics IncLXEO | +222.43% | $2.72 | $8.77 | 2025-05-30 - 2025-10-16 | Strong Buy |
Biohaven LtdBHVN | +174.33% | $14.65 | $40.19 | 2023-01-04 - 2024-01-03 | Strong Buy |
Edgewise Therapeutics IncEWTX | +132.39% | $7.75 | $18.01 | 2023-06-30 - 2024-06-28 | Strong Buy |
Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
---|---|---|---|---|---|---|
Acadia Pharmaceuticals IncACAD | 10 | Strong Buy | $33.00 | +60.04% | Maintains | 18 days ago |
Edgewise Therapeutics IncEWTX | 9 | Strong Buy | $30.00 | +95.82% | Maintains | 2 months ago |
Dyne Therapeutics IncDYN | 6 | Hold | $9.00 | -45.19% | Maintains | 3 months ago |
Biohaven LtdBHVN | 7 | Strong Buy | $55.00 | +233.74% | Maintains | 4 months ago |
Cytokinetics IncCYTK | 5 | Strong Buy | $53.00 | -10.11% | Maintains | 4 months ago |
Lexeo Therapeutics IncLXEO | 2 | Strong Buy | $10.00 | +14.03% | Maintains | 5 months ago |
Upstream Bio IncUPB | 1 | Strong Buy | $38.00 | +70.56% | Initiates Coverage On | a year ago |
Neumora Therapeutics IncNMRA | 4 | Hold | $15.00 | +742.70% | Downgrades | a year ago |
Scholar Rock Holding CorpSRRK | 4 | Strong Buy | $31.00 | N/A | Maintains | a year ago |
Eyepoint Pharmaceuticals IncEYPT | 3 | Strong Buy | $29.00 | N/A | Maintains | a year ago |
Agios Pharmaceuticals IncAGIO | 6 | Hold | $46.00 | N/A | Reinstates | a year ago |
Y Mabs Therapeutics IncYMAB | 5 | Strong Sell | $7.00 | N/A | Maintains | 2 years ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $55.00 | N/A | Maintains | 2 years ago |
Seres Therapeutics IncMCRB | 1 | Hold | $140.00 | N/A | Initiates Coverage On | 2 years ago |
Global Blood Therapeutics IncGBT | 2 | Hold | $36.00 | N/A | Maintains | 3 years ago |
Orchard Therapeutics PLCORTX | 1 | Strong Buy | $150.00 | N/A | Assumes | 5 years ago |